Sustained weight loss could make dual GLP-1/GIP receptor agonists more attractive to payers, and increase the affordability of these drugs for healthcare systems
Including both names Retatrutide and LY3437943 helps distinguish the compound in scientific, commercial, and research-oriented contexts
No data beyond 5 years for any GLP-1/GIP agonist Potential for tolerance
In such instances, your doctor may prescribe a GLP-1 receptor agonist medication like semaglutide, sold under the brand names Mounjaro, Ozempic, Rybelsus, and Wegovy, to help
Tirzepatide helps with liver fat, but the glucagon-mediated effect in retatrutide is in a different category entirely
Minimize light exposure (store in original packaging/opaque container where possible)